I’m an emergency doctor. Here are the 5 most harmful myths about COVID-19 testing

{ object.primary_image.title }}

No, less testing will not result in fewer cases. As the coronavirus crisis rages across the U.S., reaching new record daily highs some four months into the pandemic, the country is still struggling to create a coordinated, nationwide testing system. With cases skyrocketing in dozens of states, the need for adequate testing has never been more dire. Meanwhile, spurred by fear and confusion, misinformation about COVID-19 testing continues to spread in step with the virus. Read Full Story

Read Full Article on Fast Company

This COVID-19 super antibody test could provide new insights into immunity

{ object.primary_image.title }}

Dr. David Walt’s test isn’t just about telling if an individual has had COVID-19. It might change how we develop treatments and vaccines. COVID-19 antibody tests have been the subject of scrutiny since their arrival, but they still represent an important tool in understanding population health. Molecular tests have become the top method of identifying cases of COVID-19. One scientist thinks we should be looking at using a combination of antibody tests, antigen tests, and molecular RNA tests to better understand who has COVID-19 and whether or not they’re actively recovering. Read Full Story

More

Is Trump likely to get severe COVID-19? This company thinks genes could reveal clues

{ object.primary_image.title }}

A new study could help illuminate “who gets the sniffles and who ends up in the ICU,” says genetic testing company GoodCell’s chief medical officer. There has been ample speculation about the nature of President Donald Trump’s COVID-19 diagnosis, with conflicting reports creating confusion around the severity of his illness. Is the president on the mend, or is his case of COVID-19 about to get a lot worse? GoodCell, a company that offers genetic testing and biobanking, is launching a study to better understand whether genes can tell us something about who is likely to have a bad reaction to COVID-19. Read Full Story

More

This clever COVID-19 testing technique could help send kids back to school safely

{ object.primary_image.title }}

Companies are now developing pooled testing as a way of detecting coronavirus’s presence in a community earlier. The U.S. has conducted some 52 million COVID-19 tests, but it’s still not enough. Many epidemiologists believe that broadly testing people with or without symptoms is the way to root out cases of COVID-19 and develop better strategies for curbing the spread of the disease. To do that, public health experts are now discussing a technique called pooled testing—testing a batch of human samples together for COVID-19. Read Full Story

More

Opinion: The government should ensure payment for at-home COVID-19 testing

{ object.primary_image.title }}

The CEO of telehealth company Hims & Hers, which is coordinating efforts with the F.D.A., argues that affordable home testing will unburden the health system—and help get the economy going. At-home testing for COVID-19 is crucial for controlling the virus in the United States, which has become the epicenter of the global pandemic. As of writing this, more than 760,000 cases have been confirmed (and that number will have only grown since publication). Read Full Story

More

The president of Harvard University has tested positive for COVID-19

{ object.primary_image.title }}

It’s the latest high-profile case in the ongoing coronavirus crisis. In an email to the Harvard community, Larry Bacow, Harvard’s president, says he and his wife, Adele, have both tested positive for COVID-19. On Sunday, they experienced their first symptoms, which included fevers, chills, and muscle aches. On Monday they were tested, and on Tuesday they received the results of the test. They’re among a growing number of high-profile people who have tested positive for the illness in recent days, including Senator Rand Paul of Kentucky and actor Idris Elba. Read Full Story

More

COVID-19 antibody tests are here. But can you trust them?

{ object.primary_image.title }}

Antibody tests, which show if someone has successfully fought COVID-19, could help people get back to work. But companies are selling them without FDA approval, leading to questions about their accuracy. Companies usually turn to the firm PeopleG2 to run background checks on employees. Now, they can use PeopleG2 to buy up blocks of COVID-19 tests to see if workers have developed immunity to the disease. Read Full Story

More

How many COVID-19 infections are undetected? Studying its mutations may hold the answer

{ object.primary_image.title }}

In some areas, more than 90% of cases may not be showing up in the data. As of the end of June, there were more than 10.4 million confirmed cases of COVID-19 worldwide. The real number, of course, is much higher, though unknown, because of limited tests and because of how many people who are infected never have symptoms and so never think to get a test. At the nonprofit Chan Zuckerberg Biohub, researchers are using changes in the virus genome to estimate the number of undetected infections—and found that in some areas, more than 90% of cases weren’t discovered. Read Full Story

More

This new model is predicting COVID outbreaks in 5 new hotspots

{ object.primary_image.title }}

According to Urban Footprint, which is combining economic data and information from connected thermometers, areas of Michigan, Missouri, Illinois, Texas, and Washington are heading into dangerous territory. Using smart thermometers that collect data about where people have fevers, it’s possible to estimate how many of those fevers might be due to COVID-19—and predict hotspots before patients go to the doctor for coronavirus tests. A new analysis uses that data to map out where cases may soon spike. Read Full Story

More

Subscribe to our newsletter

Join our newsletter and never miss out trending marketing news.

HitcountVariables(pk=6150, ajax_url='/api/hit/ajax/', hits='7')